FR2501507B1 - - Google Patents

Info

Publication number
FR2501507B1
FR2501507B1 FR8203942A FR8203942A FR2501507B1 FR 2501507 B1 FR2501507 B1 FR 2501507B1 FR 8203942 A FR8203942 A FR 8203942A FR 8203942 A FR8203942 A FR 8203942A FR 2501507 B1 FR2501507 B1 FR 2501507B1
Authority
FR
France
Prior art keywords
insulin
novel
magnesium
preparations
calcuim
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8203942A
Other languages
English (en)
French (fr)
Other versions
FR2501507A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Industri AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri AS filed Critical Novo Industri AS
Publication of FR2501507A1 publication Critical patent/FR2501507A1/fr
Application granted granted Critical
Publication of FR2501507B1 publication Critical patent/FR2501507B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Dental Preparations (AREA)
FR8203942A 1981-03-10 1982-03-09 Expired FR2501507B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8107423 1981-03-10
DK414381 1981-09-18

Publications (2)

Publication Number Publication Date
FR2501507A1 FR2501507A1 (enExample) 1982-09-17
FR2501507B1 true FR2501507B1 (enExample) 1986-04-18

Family

ID=26067363

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8203942A Expired FR2501507B1 (enExample) 1981-03-10 1982-03-09

Country Status (14)

Country Link
US (1) US4472385A (enExample)
EP (1) EP0060141B1 (enExample)
AT (1) ATE23269T1 (enExample)
AU (1) AU550068B2 (enExample)
CA (1) CA1170990A (enExample)
CH (1) CH652031A5 (enExample)
DE (1) DE3274064D1 (enExample)
ES (1) ES510245A0 (enExample)
FI (1) FI78838C (enExample)
FR (1) FR2501507B1 (enExample)
GB (1) GB2094145B (enExample)
IE (1) IE52904B1 (enExample)
IT (1) IT1150639B (enExample)
NO (1) NO157843C (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485580D1 (de) * 1983-12-16 1992-04-16 Aoki Thomas Takemi Sacramento Algorithmus zur verabreichung von insulin.
PH23446A (en) * 1986-10-20 1989-08-07 Novo Industri As Peptide preparations
DE10075034I1 (de) * 1987-02-25 2001-05-23 Novo Nordisk As Insulinderivate
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
DE69708121T3 (de) 1996-06-20 2012-05-16 Novo Nordisk A/S Halogenid-enthaltende insulinzubereitungen
AR012894A1 (es) 1997-06-13 2000-11-22 Lilly Co Eli Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
WO1999034821A1 (en) * 1998-01-09 1999-07-15 Novo Nordisk A/S Stabilised insulin compositions
US20020156434A1 (en) * 1998-03-13 2002-10-24 Minimed Inc. Stabilizing catheter for protein drug delivery
DE60335797D1 (de) 2002-05-07 2011-03-03 Novo Nordisk As Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
US20030226223A1 (en) 2002-06-11 2003-12-11 The Procter & Gamble Co. High efficiency electric toothbrush
US7322066B2 (en) 2003-07-16 2008-01-29 Church & Dwight Co., Inc. Electric toothbrushes having movable, intermittently movable, and fixed bristles
US20050053895A1 (en) 2003-09-09 2005-03-10 The Procter & Gamble Company Attention: Chief Patent Counsel Illuminated electric toothbrushes emitting high luminous intensity toothbrush
US20050050659A1 (en) 2003-09-09 2005-03-10 The Procter & Gamble Company Electric toothbrush comprising an electrically powered element
FR2896164B1 (fr) * 2006-01-18 2008-07-04 Flamel Technologies Sa Formulation colloidale d'insuline longue action et sa preparation
FR2943538B1 (fr) * 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
CN104902922B (zh) 2012-11-13 2017-12-12 阿道恰公司 包含经取代阴离子化合物的速效胰岛素制剂
US20150273022A1 (en) * 2014-02-10 2015-10-01 Biodel Inc. Stabilized ultra-rapid-acting insulin formulations
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR892194A (fr) * 1938-06-29 1944-03-30 Ig Farbenindustrie Ag Procédé de fabrication de préparations à base d'insuline
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) * 1959-06-16 1964-03-31 Henry Marinus Dr Christensen Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states

Also Published As

Publication number Publication date
NO157843B (no) 1988-02-22
ATE23269T1 (de) 1986-11-15
DE3274064D1 (en) 1986-12-11
IT1150639B (it) 1986-12-17
IE820536L (en) 1982-09-10
FR2501507A1 (enExample) 1982-09-17
FI820808L (fi) 1982-09-11
IE52904B1 (en) 1988-04-13
GB2094145B (en) 1984-12-05
IT8220038A0 (it) 1982-03-09
EP0060141B1 (en) 1986-11-05
NO157843C (no) 1988-06-01
ES8302462A1 (es) 1983-01-16
CH652031A5 (de) 1985-10-31
EP0060141A3 (en) 1983-08-24
AU8111482A (en) 1982-09-16
GB2094145A (en) 1982-09-15
FI78838B (fi) 1989-06-30
EP0060141A2 (en) 1982-09-15
US4472385A (en) 1984-09-18
AU550068B2 (en) 1986-02-27
NO820742L (no) 1982-09-13
CA1170990A (en) 1984-07-17
FI78838C (fi) 1989-10-10
ES510245A0 (es) 1983-01-16

Similar Documents

Publication Publication Date Title
FR2501507B1 (enExample)
ES8500060A1 (es) Un metodo de producir una solucion de insulina.
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
PT85949A (en) Process for the preparation of insulin compositions containing magnesium ions
JO1502B1 (en) New pharmacy vehicles
GR3001185T3 (en) Stable solid pharmaceutical composition containing ibuprofen and codeine
AU3683484A (en) The use of menthol to enhance transdermal drug delivery
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
ES425303A1 (es) Un procedimiento de fabricacion de sales de heparina sim- ples.
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
JPS5782318A (en) Novel drug composition containing zinc salt
AU609134B2 (en) Composition containing ferric complex salt
IL65445A0 (en) New derivatives of phenyl aliphatic carboxylic acids,their preparation,their use as medicaments and the compositions containing them
GR3020615T3 (en) Chitosan-based nutrient and drug compositions for administration to ruminants
LV5660A3 (lv) Panemiens pretvirusu lidzekla iegusanai
JPS56167636A (en) Use of 4-phenyl-4-oxy-2-hydroxybutanoic acid substitution derivative as drug
ES8504166A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz(b,e) oxepina.
GB1450598A (en) Insuling preparations
IT1178915B (it) Composizione farmaceutica per rin forzare i vasi sanguigni
SU1630043A1 (ru) Плазмозамещающий раствор для лечения шока "мафусол"
ES8701182A1 (es) Un procedimiento para preparar sal monosodica del acido 7-d-mandelamido-3-(1-sulfometiltetrazol-5-il)tiometil-3-cefem-4-carboxilico
ES8303297A1 (es) Un procedimiento para la preparacion de un nuevo reptido activo.
DE3370155D1 (en) Indium complexes of substituted 8-hydroxy-quinolines, pharmaceutical compositions containing them and their use as antibacterial agents
ES8308927A1 (es) Procedimiento para la preparacion de 3-(5'- ribonucleotidos) de compuestos del tipo de lincomicina y clindamicina.

Legal Events

Date Code Title Description
ST Notification of lapse